Could be "Good to Great" again, only if... - Recensione dipendente - Manager presso Merck

1,0
4 set 2013
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Pay, Medical Benefits, Ability to atract talent based on the past, big pharma experience nice to have in your resume.

Svantaggi

Sr. Management lacking vision, simplicity, or clarity to communicate. Millions paid to external consultants to generate solutions. Excessive tolerance for poor performance at the Plain/Executive Director level causes stress across multiple levels. Formerly ran by scientists who cared about technology, deep scientific understanding, and a genuine commitment to getting medicine to patients, now in the hands of money minded people who only care about systematically destroying a legacy of scientific excellence. Lost scientific and technology direction. Not the place for academic excellence or intellectual curiosity.

Esplora altre recensioni su Merck

5,0
11 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Amazing to work and smart people to work around.

Svantaggi

Not sponsoring in the US

4,0
2 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Over my tenure, I had the opportunity to work alongside highly talented and mission-driven colleagues dedicated to improving patient outcomes. The organization provided exposure to cross-functional collaboration, leadership development opportunities, and meaningful work supporting healthcare providers, patients, and community stakeholders. I appreciated the company's commitment to innovation, professional growth, and serving patients through scientific advancement.

Svantaggi

Like many large organizations, priorities and organizational structures evolved over time, which occasionally created uncertainty and changes in responsibilities. Decision-making processes could sometimes be complex due to the size of the organization, and navigating multiple layers of stakeholders occasionally impacted speed and execution.

Vedi recensioni per: Utile|Valutazione|Data|Tutto